Primary Care News

Patients with systemic lupus erythematosus who are positive for anti-Ro60 or anti-Ro52 antibodies may face higher disease activity and more intensive treatment needs, according to data published in Rheumatology.

Results from the INFINITY-SWEDEHEART trial showed that Elixir Medical’s drug-eluting coronary implant was noninferior to a drug-eluting stent for target lesion failure at 1 year.

Intravenous golimumab yielded a durable clinical response through 116 weeks, with a stable safety profile, in polyarticular-course juvenile idiopathic arthritis, according to data published in The Journal of Rheumatology.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

False-positive mammography results discouraged women to return for further screenings, results from an observational cohort study published in the Annals of Internal Medicine showed.

ORLANDO, Fla. — For individuals hospitalized with intracerebral hemorrhage, increased caloric intake that led to an increase in weight was associated with higher odds of survival after 3 months, according to a poster.

Among young adults aged 19 to 30 years and early midlife adults aged 35 to 50 years, past-year use of cannabis and hallucinogens remained at “historically high” levels in 2023, according to the Monitoring the Future Panel Study Annual Report.

Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.

CHICAGO — Menopausal women who participated in weekly cognitive behavioral therapy sessions reported improvements in sexual function and depression and anxiety symptoms, researchers reported at the Annual Meeting of The Menopause Society.

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.